Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 1067 entries
Sorted by: Best Match Show Resources per page
Mitochondrial Myopathy in Follow-up of a Patient With Chronic Fatigue Syndrome.

Journal of investigative medicine high impact case reports

Galán F, de Lavera I, Cotán D, Sánchez-Alcázar JA.
PMID: 26904705
J Investig Med High Impact Case Rep. 2015 Sep 24;3(3):2324709615607908. doi: 10.1177/2324709615607908. eCollection 2015.

Introduction. Symptoms of mitochondrial diseases and chronic fatigue syndrome (CFS) frequently overlap and can easily be mistaken. Methods. We report the case of a patient diagnosed with CFS and during follow-up was finally diagnosed with mitochondrial myopathy by histochemical...

Cite
Galán F, de Lavera I, Cotán D, et al. Mitochondrial Myopathy in Follow-up of a Patient With Chronic Fatigue Syndrome. J Investig Med High Impact Case Rep. 2015;3(3):2324709615607908doi: 10.1177/2324709615607908.
Galán, F., de Lavera, I., Cotán, D., & Sánchez-Alcázar, J. A. (2015). Mitochondrial Myopathy in Follow-up of a Patient With Chronic Fatigue Syndrome. Journal of investigative medicine high impact case reports, 3(3), 2324709615607908. https://doi.org/10.1177/2324709615607908
Galán, Fernando, et al. "Mitochondrial Myopathy in Follow-up of a Patient With Chronic Fatigue Syndrome." Journal of investigative medicine high impact case reports vol. 3,3 (2015): 2324709615607908. doi: https://doi.org/10.1177/2324709615607908
Galán F, de Lavera I, Cotán D, Sánchez-Alcázar JA. Mitochondrial Myopathy in Follow-up of a Patient With Chronic Fatigue Syndrome. J Investig Med High Impact Case Rep. 2015 Sep 24;3(3):2324709615607908. doi: 10.1177/2324709615607908. eCollection 2015. PMID: 26904705; PMCID: PMC4748504.
Copy Download .nbib Format: NLM
Genome Sequence of EU-Unauthorized Genetically Modified Bacillus subtilis Strain 2014-3557 Overproducing Riboflavin, Isolated from a Vitamin B2 80% Feed Additive.

Genome announcements

Barbau-Piednoir E, De Keersmaecker SC, Wuyts V, Gau C, Pirovano W, Costessi A, Philipp P, Roosens NH.
PMID: 25858836
Genome Announc. 2015 Apr 09;3(2). doi: 10.1128/genomeA.00214-15.

This paper announces the genome sequence and annotation of the genetically modified (GM) Bacillus subtilis strain 2014-3557 overproducing riboflavin (vitamin B2). This GM-strain is unauthorized in the European Union. Nevertheless, it has been isolated from a lot of vitamin...

Cite
Barbau-Piednoir E, De Keersmaecker SC, Wuyts V, et al. Genome Sequence of EU-Unauthorized Genetically Modified Bacillus subtilis Strain 2014-3557 Overproducing Riboflavin, Isolated from a Vitamin B2 80% Feed Additive. Genome Announc. 2015;3(2)doi: 10.1128/genomeA.00214-15.
Barbau-Piednoir, E., De Keersmaecker, S. C., Wuyts, V., Gau, C., Pirovano, W., Costessi, A., Philipp, P., & Roosens, N. H. (2015). Genome Sequence of EU-Unauthorized Genetically Modified Bacillus subtilis Strain 2014-3557 Overproducing Riboflavin, Isolated from a Vitamin B2 80% Feed Additive. Genome announcements, 3(2), . https://doi.org/10.1128/genomeA.00214-15
Barbau-Piednoir, Elodie, et al. "Genome Sequence of EU-Unauthorized Genetically Modified Bacillus subtilis Strain 2014-3557 Overproducing Riboflavin, Isolated from a Vitamin B2 80% Feed Additive." Genome announcements vol. 3,2 (2015). doi: https://doi.org/10.1128/genomeA.00214-15
Barbau-Piednoir E, De Keersmaecker SC, Wuyts V, Gau C, Pirovano W, Costessi A, Philipp P, Roosens NH. Genome Sequence of EU-Unauthorized Genetically Modified Bacillus subtilis Strain 2014-3557 Overproducing Riboflavin, Isolated from a Vitamin B2 80% Feed Additive. Genome Announc. 2015 Apr 09;3(2). doi: 10.1128/genomeA.00214-15. PMID: 25858836; PMCID: PMC4392148.
Copy Download .nbib Format: NLM
Comparative mRNA Expression Profiles of Riboflavin Biosynthesis Genes in Lactobacilli Isolated from Human Feces and Fermented Bamboo Shoots.

Frontiers in microbiology

Thakur K, Tomar SK, Wei ZJ.
PMID: 28367143
Front Microbiol. 2017 Mar 17;8:427. doi: 10.3389/fmicb.2017.00427. eCollection 2017.

With the aim to bioprospect potent riboflavin producing lactobacilli, the present study was carried out to evaluate the relative mRNA expression of riboflavin biosynthesis genes namely

Cite
Thakur K, Tomar SK, Wei ZJ. Comparative mRNA Expression Profiles of Riboflavin Biosynthesis Genes in Lactobacilli Isolated from Human Feces and Fermented Bamboo Shoots. Front Microbiol. 2017;8:427doi: 10.3389/fmicb.2017.00427.
Thakur, K., Tomar, S. K., & Wei, Z. J. (2017). Comparative mRNA Expression Profiles of Riboflavin Biosynthesis Genes in Lactobacilli Isolated from Human Feces and Fermented Bamboo Shoots. Frontiers in microbiology, 8427. https://doi.org/10.3389/fmicb.2017.00427
Thakur, Kiran, et al. "Comparative mRNA Expression Profiles of Riboflavin Biosynthesis Genes in Lactobacilli Isolated from Human Feces and Fermented Bamboo Shoots." Frontiers in microbiology vol. 8 (2017): 427. doi: https://doi.org/10.3389/fmicb.2017.00427
Thakur K, Tomar SK, Wei ZJ. Comparative mRNA Expression Profiles of Riboflavin Biosynthesis Genes in Lactobacilli Isolated from Human Feces and Fermented Bamboo Shoots. Front Microbiol. 2017 Mar 17;8:427. doi: 10.3389/fmicb.2017.00427. eCollection 2017. PMID: 28367143; PMCID: PMC5356473.
Copy Download .nbib Format: NLM
In vitro binding of riboflavin to subcellular particles from maize coleoptiles and Cucurbita hypocotyls.

Planta

Hertel R, Jesaitis AJ, Dohrmann U, Briggs WR.
PMID: 24311081
Planta. 1980 Jan;147(4):312-9. doi: 10.1007/BF00379839.

Saturable and reversible in vitro binding of [(14)C]riboflavin was found to occur on subcellular, sedimentable particles from maize coleoptiles and Cucurbita hypocotyls. The KD was ca. 6 μM, the pH optimum was near 6.0, and the number of binding...

Cite
Hertel R, Jesaitis AJ, Dohrmann U, et al. In vitro binding of riboflavin to subcellular particles from maize coleoptiles and Cucurbita hypocotyls. Planta. 1980;147(4):312-9doi: 10.1007/BF00379839.
Hertel, R., Jesaitis, A. J., Dohrmann, U., & Briggs, W. R. (1980). In vitro binding of riboflavin to subcellular particles from maize coleoptiles and Cucurbita hypocotyls. Planta, 147(4), 312-9. https://doi.org/10.1007/BF00379839
Hertel, R, et al. "In vitro binding of riboflavin to subcellular particles from maize coleoptiles and Cucurbita hypocotyls." Planta vol. 147,4 (1980): 312-9. doi: https://doi.org/10.1007/BF00379839
Hertel R, Jesaitis AJ, Dohrmann U, Briggs WR. In vitro binding of riboflavin to subcellular particles from maize coleoptiles and Cucurbita hypocotyls. Planta. 1980 Jan;147(4):312-9. doi: 10.1007/BF00379839. PMID: 24311081.
Copy Download .nbib Format: NLM
Nutrition in the management of cirrhosis and its neurological complications.

Journal of clinical and experimental hepatology

Bémeur C, Butterworth RF.
PMID: 25755550
J Clin Exp Hepatol. 2014 Jun;4(2):141-50. doi: 10.1016/j.jceh.2013.05.008. Epub 2013 Jun 11.

Malnutrition is a common feature of chronic liver diseases that is often associated with a poor prognosis including worsening of clinical outcome, neuropsychiatric complications as well as outcome following liver transplantation. Nutritional assessment in patients with cirrhosis is challenging...

Cite
Bémeur C, Butterworth RF. Nutrition in the management of cirrhosis and its neurological complications. J Clin Exp Hepatol. 2013;4(2):141-50doi: 10.1016/j.jceh.2013.05.008.
Bémeur, C., & Butterworth, R. F. (2014). Nutrition in the management of cirrhosis and its neurological complications. Journal of clinical and experimental hepatology, 4(2), 141-50. https://doi.org/10.1016/j.jceh.2013.05.008
Bémeur, Chantal, and Butterworth, Roger F. "Nutrition in the management of cirrhosis and its neurological complications." Journal of clinical and experimental hepatology vol. 4,2 (2014): 141-50. doi: https://doi.org/10.1016/j.jceh.2013.05.008
Bémeur C, Butterworth RF. Nutrition in the management of cirrhosis and its neurological complications. J Clin Exp Hepatol. 2014 Jun;4(2):141-50. doi: 10.1016/j.jceh.2013.05.008. Epub 2013 Jun 11. PMID: 25755550; PMCID: PMC4116712.
Copy Download .nbib Format: NLM
Sustained therapeutic response to riboflavin in a child with a progressive neurological condition, diagnosed by whole-exome sequencing.

Cold Spring Harbor molecular case studies

Shashi V, Petrovski S, Schoch K, Crimian R, Case LE, Khalid R, El-Dairi MA, Jiang YH, Mikati MA, Goldstein DB.
PMID: 27148562
Cold Spring Harb Mol Case Stud. 2015 Oct;1(1):a000265. doi: 10.1101/mcs.a000265.

One of the most promising outcomes of whole-exome sequencing (WES) is the alteration of medical management following an accurate diagnosis in patients with previously unresolved disorders. Although case reports of targeted therapies resulting from WES have been published, there...

Cite
Shashi V, Petrovski S, Schoch K, et al. Sustained therapeutic response to riboflavin in a child with a progressive neurological condition, diagnosed by whole-exome sequencing. Cold Spring Harb Mol Case Stud. 2015;1(1):a000265doi: 10.1101/mcs.a000265.
Shashi, V., Petrovski, S., Schoch, K., Crimian, R., Case, L. E., Khalid, R., El-Dairi, M. A., Jiang, Y. H., Mikati, M. A., & Goldstein, D. B. (2015). Sustained therapeutic response to riboflavin in a child with a progressive neurological condition, diagnosed by whole-exome sequencing. Cold Spring Harbor molecular case studies, 1(1), a000265. https://doi.org/10.1101/mcs.a000265
Shashi, Vandana, et al. "Sustained therapeutic response to riboflavin in a child with a progressive neurological condition, diagnosed by whole-exome sequencing." Cold Spring Harbor molecular case studies vol. 1,1 (2015): a000265. doi: https://doi.org/10.1101/mcs.a000265
Shashi V, Petrovski S, Schoch K, Crimian R, Case LE, Khalid R, El-Dairi MA, Jiang YH, Mikati MA, Goldstein DB. Sustained therapeutic response to riboflavin in a child with a progressive neurological condition, diagnosed by whole-exome sequencing. Cold Spring Harb Mol Case Stud. 2015 Oct;1(1):a000265. doi: 10.1101/mcs.a000265. PMID: 27148562; PMCID: PMC4850881.
Copy Download .nbib Format: NLM
Late Stage of Corneal Decompensation Caused by Progressive Keratoconus: Can We Treat It and Save the Cornea?.

Case reports in ophthalmological medicine

Knezović I, Belovari Višnjić M, Raguž H.
PMID: 26064737
Case Rep Ophthalmol Med. 2015;2015:795826. doi: 10.1155/2015/795826. Epub 2015 Apr 30.

Aim. To report a case of 40-year-old male with progressive bilateral keratoconus who had undergone transepithelial phototherapeutic keratectomy (TE-PTK) and corneal collagen cross-linking (CXL) using hypoosmolar riboflavin solution in a same day procedure. Methods. Eye examination showed that UCDVA...

Cite
Knezović I, Belovari Višnjić M, Raguž H. Late Stage of Corneal Decompensation Caused by Progressive Keratoconus: Can We Treat It and Save the Cornea?. Case Rep Ophthalmol Med. 2015;2015:795826doi: 10.1155/2015/795826.
Knezović, I., Belovari Višnjić, M., & Raguž, H. (2015). Late Stage of Corneal Decompensation Caused by Progressive Keratoconus: Can We Treat It and Save the Cornea?. Case reports in ophthalmological medicine, 2015795826. https://doi.org/10.1155/2015/795826
Knezović, Igor, et al. "Late Stage of Corneal Decompensation Caused by Progressive Keratoconus: Can We Treat It and Save the Cornea?." Case reports in ophthalmological medicine vol. 2015 (2015): 795826. doi: https://doi.org/10.1155/2015/795826
Knezović I, Belovari Višnjić M, Raguž H. Late Stage of Corneal Decompensation Caused by Progressive Keratoconus: Can We Treat It and Save the Cornea?. Case Rep Ophthalmol Med. 2015;2015:795826. doi: 10.1155/2015/795826. Epub 2015 Apr 30. PMID: 26064737; PMCID: PMC4430651.
Copy Download .nbib Format: NLM
Collagen cross-linking: when and how? A review of the state of the art of the technique and new perspectives.

Eye and vision (London, England)

Mastropasqua L.
PMID: 26665102
Eye Vis (Lond). 2015 Nov 29;2:19. doi: 10.1186/s40662-015-0030-6. eCollection 2015.

Since the late 1990s corneal crosslinking (CXL) has been proposed as a new possibility to stop progression of keratoconus or secondary corneal ectasia, with the promising aim to prevent progressive visual loss due to the evolution of the pathology...

Cite
Mastropasqua L. Collagen cross-linking: when and how? A review of the state of the art of the technique and new perspectives. Eye Vis (Lond). 2015;2:19doi: 10.1186/s40662-015-0030-6.
Mastropasqua, L. (2015). Collagen cross-linking: when and how? A review of the state of the art of the technique and new perspectives. Eye and vision (London, England), 219. https://doi.org/10.1186/s40662-015-0030-6
Mastropasqua, Leonardo. "Collagen cross-linking: when and how? A review of the state of the art of the technique and new perspectives." Eye and vision (London, England) vol. 2 (2015): 19. doi: https://doi.org/10.1186/s40662-015-0030-6
Mastropasqua L. Collagen cross-linking: when and how? A review of the state of the art of the technique and new perspectives. Eye Vis (Lond). 2015 Nov 29;2:19. doi: 10.1186/s40662-015-0030-6. eCollection 2015. PMID: 26665102; PMCID: PMC4675057.
Copy Download .nbib Format: NLM
Riboflavin binding proteins as chiral selectors in HPLC and CE.

Pharmaceutical science & technology today

De Lorenzi E, Massolini G.
PMID: 10470023
Pharm Sci Technol Today. 1999 Sep;2(9):352-364. doi: 10.1016/s1461-5347(99)00189-3.

The term riboflavin binding proteins (RfBPs) is applied to several molecular species that play the important role of vitamin delivery to the developing embryo, thus becoming essential for the survival of the fetus. In addition to this physiological significance,...

Cite
De Lorenzi E, Massolini G. Riboflavin binding proteins as chiral selectors in HPLC and CE. Pharm Sci Technol Today. 1999;2(9):352-364doi: 10.1016/s1461-5347(99)00189-3.
De Lorenzi E, & Massolini, G. (1999). Riboflavin binding proteins as chiral selectors in HPLC and CE. Pharmaceutical science & technology today, 2(9), 352-364. https://doi.org/10.1016/s1461-5347(99)00189-3
De Lorenzi E, and Massolini. "Riboflavin binding proteins as chiral selectors in HPLC and CE." Pharmaceutical science & technology today vol. 2,9 (1999): 352-364. doi: https://doi.org/10.1016/s1461-5347(99)00189-3
De Lorenzi E, Massolini G. Riboflavin binding proteins as chiral selectors in HPLC and CE. Pharm Sci Technol Today. 1999 Sep;2(9):352-364. doi: 10.1016/s1461-5347(99)00189-3. PMID: 10470023.
Copy Download .nbib Format: NLM
Effects of Ascorbic Acid on the Light-Induced Riboflavin Degradation and Color Changes in Milks.

Journal of agricultural and food chemistry

Lee KH, Jung MY, Kim SY.
PMID: 10554254
J Agric Food Chem. 1998 Feb 16;46(2):407-410. doi: 10.1021/jf9707086.

Effects of ascorbic acid (0.025, 0.05, and 0.1%, w/v) on the light-induced riboflavin degradation and color changes in whole and skim milks were studied during 10 h fluorescent light illumination at 7 +/- 2 degrees C. As the time...

Cite
Lee KH, Jung MY, Kim SY. Effects of Ascorbic Acid on the Light-Induced Riboflavin Degradation and Color Changes in Milks. J Agric Food Chem. 1998;46(2):407-410doi: 10.1021/jf9707086.
Lee, K. H., Jung, M. Y., & Kim, S. Y. (1998). Effects of Ascorbic Acid on the Light-Induced Riboflavin Degradation and Color Changes in Milks. Journal of agricultural and food chemistry, 46(2), 407-410. https://doi.org/10.1021/jf9707086
Lee, et al. "Effects of Ascorbic Acid on the Light-Induced Riboflavin Degradation and Color Changes in Milks." Journal of agricultural and food chemistry vol. 46,2 (1998): 407-410. doi: https://doi.org/10.1021/jf9707086
Lee KH, Jung MY, Kim SY. Effects of Ascorbic Acid on the Light-Induced Riboflavin Degradation and Color Changes in Milks. J Agric Food Chem. 1998 Feb 16;46(2):407-410. doi: 10.1021/jf9707086. PMID: 10554254.
Copy Download .nbib Format: NLM
Enzymatic and nonenzymatic mechanisms for ferric leghemoglobin reduction in legume root nodules.

Proceedings of the National Academy of Sciences of the United States of America

Becana M, Klucas RV.
PMID: 11607104
Proc Natl Acad Sci U S A. 1990 Sep;87(18):7295-9. doi: 10.1073/pnas.87.18.7295.

Evidence is presented for the operation in nodules of at least four systems for restoring functional ferrous leghemoglobin (LB2+) from its inactive, ferric form. (i) Reduction of ferric leghemoglobin (LB3+) by a reductase. The enzyme is a flavoprotein of...

Cite
Becana M, Klucas RV. Enzymatic and nonenzymatic mechanisms for ferric leghemoglobin reduction in legume root nodules. Proc Natl Acad Sci U S A. 1990;87(18):7295-9doi: 10.1073/pnas.87.18.7295.
Becana, M., & Klucas, R. V. (1990). Enzymatic and nonenzymatic mechanisms for ferric leghemoglobin reduction in legume root nodules. Proceedings of the National Academy of Sciences of the United States of America, 87(18), 7295-9. https://doi.org/10.1073/pnas.87.18.7295
Becana, M, and Klucas, R V. "Enzymatic and nonenzymatic mechanisms for ferric leghemoglobin reduction in legume root nodules." Proceedings of the National Academy of Sciences of the United States of America vol. 87,18 (1990): 7295-9. doi: https://doi.org/10.1073/pnas.87.18.7295
Becana M, Klucas RV. Enzymatic and nonenzymatic mechanisms for ferric leghemoglobin reduction in legume root nodules. Proc Natl Acad Sci U S A. 1990 Sep;87(18):7295-9. doi: 10.1073/pnas.87.18.7295. PMID: 11607104; PMCID: PMC54730.
Copy Download .nbib Format: NLM
Synthesis and Biochemical Evaluation of Bis(6,7-dimethyl-8-D-ribityllumazines) as Potential Bisubstrate Analogue Inhibitors of Riboflavin Synthase.

The Journal of organic chemistry

Cushman M, Mavandadi F, Yang D, Kugelbrey K, Kis K, Bacher A.
PMID: 11674533
J Org Chem. 1999 Jun 25;64(13):4635-4642. doi: 10.1021/jo9821731.

The reaction catalyzed by riboflavin synthase utilizes two identical 6,7-dimethyl-8-D-ribityllumazine substrate molecules. Three bis(6,7-dimethyl-8-D-ribityllumazines) were, therefore, synthesized in which the two lumazine moieties were connected through their N-3 nitrogen atoms by polymethylene linker chains containing three, four, and five...

Cite
Cushman M, Mavandadi F, Yang D, et al. Synthesis and Biochemical Evaluation of Bis(6,7-dimethyl-8-D-ribityllumazines) as Potential Bisubstrate Analogue Inhibitors of Riboflavin Synthase. J Org Chem. 1999;64(13):4635-4642doi: 10.1021/jo9821731.
Cushman, M., Mavandadi, F., Yang, D., Kugelbrey, K., Kis, K., & Bacher, A. (1999). Synthesis and Biochemical Evaluation of Bis(6,7-dimethyl-8-D-ribityllumazines) as Potential Bisubstrate Analogue Inhibitors of Riboflavin Synthase. The Journal of organic chemistry, 64(13), 4635-4642. https://doi.org/10.1021/jo9821731
Cushman, Mark, et al. "Synthesis and Biochemical Evaluation of Bis(6,7-dimethyl-8-D-ribityllumazines) as Potential Bisubstrate Analogue Inhibitors of Riboflavin Synthase." The Journal of organic chemistry vol. 64,13 (1999): 4635-4642. doi: https://doi.org/10.1021/jo9821731
Cushman M, Mavandadi F, Yang D, Kugelbrey K, Kis K, Bacher A. Synthesis and Biochemical Evaluation of Bis(6,7-dimethyl-8-D-ribityllumazines) as Potential Bisubstrate Analogue Inhibitors of Riboflavin Synthase. J Org Chem. 1999 Jun 25;64(13):4635-4642. doi: 10.1021/jo9821731. PMID: 11674533.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 1067 entries